| Hans-Günter Meyer-Thompson | Opioide
USA. Public Health: Dangers Of Opana Opioid Painkiller Outweigh Benefits, FDA Panel Says
An advisory panel convened by the Food and Drug Administration to evaluate the health risks of the powerful opioid painkiller Opana ER (Oxymorphone retard, Anmerkung Forum Substitutionspraxis) says that the danger it poses as a drug of abuse outweighs its benefits as a prescription painkiller.
The time-release opioid was reformulated in 2012 to make it harder to crush. The goal was to reduce abuse by snorting it. But users quickly figured out that the new formulation could be dissolved and injected. (npr, 16.03.2017)